392 views

Igloo raises $19m in Series B funding round

This brings its total funding to over $36m.

Igloo has raised an additional $19m in a Series B funding round led by Cathay Innovation, with participation from ACA and Openspace.

This brings the total fundings of the insurtech firm to over $36m.
Igloo said it plans to use the fresh funds for driving product innovation as well as cementing itself as the leading insurtech firm in Southeast Asia.

Raunak Mehta named as new CEO and co-founder

At the same time as the announcement for its new funding, Igloo has promoted Raunak Mehta as the new Igloo CEO and co-founder.

Igloo's new co-founder and CEO Raunak Mehta.

Raunak previously held the position of COO in the company. He has has extensive experience in the e-commerce and technology space, having held leadership roles at Asia’s biggest e-commerce brands Flipkart and Zalora. Since joining Igloo in 2018, he has spearheaded its market entry into The Philippines, Vietnam, Thailand, Indonesia, Australia and Malaysia. while establishing partnerships with industry leaders such as Lazada, Shopee, Bukalapak, AIS, RedDoorz, foodpanda, Lotte Finance and Ahamove across a range of insurance products.

Since 2019, Igloo has facilitated over 200 million policies across SEA.
 

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.